NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-129-2021-0-BR-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction BR National Stage BR112024002194-7 Pending
NCATS E-116-2016-0-CA-01 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE CA DIV 3228060 Pending
NCI E-048-2021-0-CA-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION CA National Stage 3228275 Pending
NIDCR E-129-2021-0-PH-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction PH National Stage 1-2024-550312 Pending
NIDCR E-129-2021-0-SG-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction SG National Stage 11202400787X Pending
NEI E-015-2019-0-CN-06 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CN DIV 202410147518.1 Pending
NIDCR E-129-2021-0-MX-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction MX National Stage MX/a/2024/001577 Pending
NCI E-494-2013-0-US-02 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 18/430,031 Pending
NEI E-005-2023-0-PC-01 SYSTEMS AND METHODS FOR DEEP LEARNING TO DETECT RETINAL VASCULITIS ON COLOR FUNDUS PHOTOGRAPHS OF PATIENTS WITH UVEITIS PCT PCT PCT/US2024/013833 Pending
NCI E-055-2017-0-US-02 Combination Therapy of Immunotoxin and Checkpoint Inhibitor US CON 18/428,597 Pending
NIDCR E-129-2021-0-US-02 AQP1 GENE THERAPY TO PREVENT RADIATION INDUCED SALIVARY HYPOFUNCTION US National Stage 18/294,048 Pending
NIDCR E-129-2021-0-CA-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction CA National Stage 3227584 Pending
NINDS E-070-2024-0-PC-01 Combination Treatment of Multiple Sclerosis PCT PCT PCT/US2024/013658 Pending
NIAID E-178-2022-0-PC-01 EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY PCT PCT PCT/US2024/013311 Pending
NHLBI E-090-2020-0-US-02 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND
METHODS OF USE 		US DIV 18/425,487 Pending
NINDS E-117-2021-1-EP-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. EP National Stage 22761746.1 Pending
NIDCR E-129-2021-0-IL-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction IL National Stage 310485 Pending
NIAID E-050-2018-0-US-08 NIPAH VIRUS IMMUNOGENS AND THEIR USE US DIV 18/424,606 Pending
NCI E-199-2022-0-PC-01 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY PCT PCT PCT/US2024/012976 Pending
NCI E-175-2016-0-US-02 ANTI-KRAS-G12D T CELL RECEPTORS US CON 18/423,020 Pending
NCI E-048-2021-0-AU-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION AU National Stage 2022323509 Pending
NHLBI E-039-2022-0-US-02 TEMPERATURE CYCLING METHOD FOR HYPERPOLARIZATION OF TARGET MOLECULES AND CONTRAST AGENTS USING PARAHYDROGEN US National Stage 18/291,681 Pending
NIAID E-052-2017-4-AU-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection AU DIV 2024200395 Pending
NHLBI E-091-2021-0-EP-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE EP National Stage 22743679.7 Pending
NICHD E-209-2021-0-US-04 Kits And Methods To Distinguish False Labor And True Labor US CON 18/414,339 Pending
NCI E-150-2017-2-HK-02 Diagnostic Methods For T Cell Therapy HK EP 42024085326.7 Pending
NIAID E-135-2010-0-US-02 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 18/411,997 Pending
NCATS E-114-2018-0-JP-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS JP DIV 2024-003447 Pending
NCI E-053-2024-0-PC-01 PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY PCT PCT PCT/US2024/011463 Pending
NINDS E-047-2023-1-PC-01 Genetic control of MRI signal PCT PCT PCT/US2024/011377 Pending
NCI E-094-2017-0-CN-01 Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy CN DIV 202410048366.X Pending
NCI E-058-2023-0-PC-01 BICYCLIC CARBAMOYL PYRIDONE-BASED INTEGRASE STRAND TRANSFER INHIBITORS PCT PCT PCT/US2024/011244 Pending
NHLBI E-036-2022-0-US-03 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS US CIP 18/410,773 Pending
NCI E-181-2017-0-CR-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CR DIV 2024-0019 Pending
NIBIB E-040-2023-1-PC-01 INTUBATION SYSTEM AND CHAMBER TANK PCT PCT PCT/US2024/011071 Pending
NIAID E-064-2016-1-US-10 PREFUSION RSV F PROTEINS AND THEIR USE US CON 18/409,645 Pending
NIAID E-052-2017-0-TW-01 Trispecific Binding Protein TW DIV 113100534 Pending
NEI E-293-2016-0-JP-09 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2024-617 Pending
NHGRI E-034-2019-0-JP-01 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA JP DIV 2024-000692 Pending
NEI E-164-2021-0-JP-01 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY JP National Stage 2024-525189 Pending
NCATS E-192-2022-0-PC-03 SDR Assay: A General High Throughout Binding Assay Strategy Based On A Ligand-biased Structural Dynamics Response. PCT PCT PCT/US2024/010333 Pending
NEI E-164-2021-0-MX-01 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY MX National Stage MX/a/2024/000309 Pending
NHLBI E-054-2024-0-PC-01 SYSTEM AND METHOD FOR VARIABLE-FLIP-ANGLE 3D SPIRAL-IN-OUT TSE/SPACE PCT PCT PCT/US2024/010067 Pending
NHLBI E-054-2024-0-US-02 System and Method for Variable-flip-angle 3D Spiral-in-out TSE/SPACE Using Echo-reordering and Concomitant Gradient Compensation US ORD 18/402,593 Pending
NCI E-101-2021-0-CN-05 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 CN National Stage 202280047288.0 Pending
NHLBI E-057-2024-0-EP-01 Use of LMO4 to bolster stemness and antitumor efficacy of T-cells EP ORD 24150070.1 Pending
NIDDK E-032-2023-0-PC-01 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION PCT PCT COMB PCT/US2023/085968 Pending
NCI E-067-2017-0-US-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES US DIV 18/397,448 Pending
NCI E-205-2010-2-JP-01 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2023-220785 Pending
NCI E-175-2016-0-JP-01 ANTI-KRAS-G12D T CELL RECEPTORS JP DIV 2023-221526 Pending